Eli Lilly Targets Netherlands with US$3 billion Investment

U.S. pharma major Eli Lilly and Company (Indianapolis, Indiana) has announced plans to spend US$3 billion to build an oral medicines manufacturing facility in Katwijk, Netherlands. The decision follows an aggressive expansion plan announced for the U.S. earlier this year where it plans to spend US$27 billion on four new production plants. The new plant in south Holland will be constructed in two phases, comprising a 753,000 square foot (sqft) facility to start and another 800,000 sqft facility t